ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,893.62
0.39%
US Tech 100
19,987.20
0.63%
Dow Jones
43,389.60
-0.13%
Brent Oil
72.935
3.15%
Bitcoin
90,691.67
0.92%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Tango Therapeutics Inc (TNGX)

  7. Tango Therapeutics Inc (TNGX) News

Tango Therapeutics Inc

Tango Therapeutics Inc (TNGX)

NASDAQ
3.60
-0.25
(-6.49%)
At close: November 18 4:00PM
Delayed by 15 minutes
3.55
-0.05
( -1.39% )
After Hours: 6:00PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

TNGX News

Official News Only

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Edgar (US Regulatory)
November 07 2024
TNGX (-6.49%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
November 06 2024
TNGX (-6.49%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
November 06 2024
TNGX (-6.49%)

Form 8-K - Current report
Edgar (US Regulatory)
November 06 2024
TNGX (-6.49%)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Edgar (US Regulatory)
October 28 2024
TNGX (-6.49%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
October 25 2024
TNGX (-6.49%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
October 22 2024
TNGX (-6.49%)

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
October 22 2024
TNGX (-6.49%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
October 22 2024
TNGX (-6.49%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
August 07 2024
TNGX (-6.49%)

Form 8-K - Current report
Edgar (US Regulatory)
August 07 2024
TNGX (-6.49%)

TNGX Discussion

View Posts
Monksdream Monksdream 5 months ago
TNGX under $10
👍️0
Monksdream Monksdream 7 months ago
TNGX under $10
👍️0
bikaver bikaver 1 year ago
Stopped out with small loss.
👍️0
bikaver bikaver 1 year ago
TNGX......Holding up well, but will tumble soon.
👍️0
bikaver bikaver 1 year ago
TNGA.....short @ 8.60 This is the strength that I wanted to see!
👍️0
bikaver bikaver 1 year ago
TNGX.....Studying the TNGX chart this evening. I'll short it at a good sign of strength if the opportunity presents itself tomorrow.
👍️0
SmokeSignals SmokeSignals 1 year ago
up $4>H.C. Wainwright Reaffirms Their Buy Rating on Tango Therapeutics (TNGX)AUGUST 8, 2023TIPRANKS
Barclays Releases a Buy Rating on Tango Therapeutics (TNGX)AUGUST 8, 2023TIPRANKS
Goldman Sachs Keeps Their Buy Rating on Tango Therapeutics (TNGX)AUGUST 7, 2023TIPRANKS
Tango Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business HighlightsAUGUST 7, 2023TIPRANKS
Tango Therapeutics reports Q2 EPS (23c), consensus (34c)AUGUST 7, 2023TIPRANKS
👍️0

Your Recent History

NASDAQ
TNGX
Tango Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved